128 related articles for article (PubMed ID: 28816927)
21. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
[TBL] [Abstract][Full Text] [Related]
22. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.
Dubnov-Raz G; Hemilä H; Vurembrand Y; Kuint J; Maayan-Metzger A
Early Hum Dev; 2012 Mar; 88(3):191-4. PubMed ID: 21890289
[TBL] [Abstract][Full Text] [Related]
23. Effects of antidepressants on postmenopausal bone loss - A 5-year longitudinal study from the OSTPRE cohort.
Rauma PH; Honkanen RJ; Williams LJ; Tuppurainen MT; Kröger HP; Koivumaa-Honkanen H
Bone; 2016 Aug; 89():25-31. PubMed ID: 27179631
[TBL] [Abstract][Full Text] [Related]
24. [Selective serotonin reuptake inhibitors (SSRI) and osteoporosis].
Fétique-Will AC; Chevalley T; Rizzoli R
Rev Med Suisse; 2011 Jun; 7(299):1299-304. PubMed ID: 21793419
[TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.
Wu Q; Bencaz AF; Hentz JG; Crowell MD
Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950
[TBL] [Abstract][Full Text] [Related]
26. Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
Haney EM; Warden SJ; Bliziotes MM
Bone; 2010 Jan; 46(1):13-7. PubMed ID: 19664737
[TBL] [Abstract][Full Text] [Related]
27. Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.
Sathianathen NJ; Hwang EC; Mian R; Bodie JA; Soubra A; Lyon JA; Sultan S; Dahm P
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012799. PubMed ID: 33745183
[TBL] [Abstract][Full Text] [Related]
28. SSRIs, bone mineral density, and risk of fractures--a review.
Schwan S; Hallberg P
Eur Neuropsychopharmacol; 2009 Oct; 19(10):683-92. PubMed ID: 19541458
[TBL] [Abstract][Full Text] [Related]
29. Associations between objectively-measured sedentary behaviour and physical activity with bone mineral density in adults and older adults, the NHANES study.
Chastin SF; Mandrichenko O; Helbostadt JL; Skelton DA
Bone; 2014 Jul; 64():254-62. PubMed ID: 24735973
[TBL] [Abstract][Full Text] [Related]
30. Use of Selective Serotonin Reuptake Inhibitors and Sleep Quality: A Population-Based Study.
Aarts N; Zuurbier LA; Noordam R; Hofman A; Tiemeier H; Stricker BH; Visser LE
J Clin Sleep Med; 2016 Jul; 12(7):989-95. PubMed ID: 27092698
[TBL] [Abstract][Full Text] [Related]
31. The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.
Rauma PH; Pasco JA; Berk M; Stuart AL; Koivumaa-Honkanen H; Honkanen RJ; Hodge JM; Williams LJ
J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):177-85. PubMed ID: 26032210
[TBL] [Abstract][Full Text] [Related]
32. The adverse skeletal effects of selective serotonin reuptake inhibitors.
Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
[TBL] [Abstract][Full Text] [Related]
33. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
34. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
[TBL] [Abstract][Full Text] [Related]
36. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
Nguyen TV; Sambrook PN; Eisman JA
J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
[TBL] [Abstract][Full Text] [Related]
37. [Effect of SSRIs on bone metabolism].
Kerbage H; Bahadori S; Léger J; Carel JC; Purper Ouakil D
Encephale; 2014 Feb; 40(1):56-61. PubMed ID: 23810751
[TBL] [Abstract][Full Text] [Related]
38. Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men.
Williams LJ; Berk M; Hodge JM; Kotowicz MA; Stuart AL; Chandrasekaran V; Cleminson J; Pasco JA
Calcif Tissue Int; 2018 Aug; 103(2):125-130. PubMed ID: 29441424
[TBL] [Abstract][Full Text] [Related]
39. Dietary inflammatory index and bone mineral density in Mexican population.
Rivera-Paredez B; Quezada-Sánchez AD; Robles-Rivera K; Hidalgo-Bravo A; Denova-Gutiérrez E; León-Reyes G; Flores YN; Salmerón J; Velázquez-Cruz R
Osteoporos Int; 2022 Sep; 33(9):1969-1979. PubMed ID: 35624319
[TBL] [Abstract][Full Text] [Related]
40. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
